Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1978 Apr;37(4):505–513. doi: 10.1038/bjc.1978.78

Relationship of cell-mediated cytotoxicity against melanoma cells to prognosis in melanoma patients.

P Hershey, A Edwards, G W Milton, W H McCarthy
PMCID: PMC2009547  PMID: 646923

Abstract

The cell-mediated cytotoxicity (CMC) of blood mononuclear cells against cultured human melanoma cells was measured in patients after surgical removal of localized melanoma, at a time when they were considered on clinical grounds to be free of melanoma. It was found that the distribution of CMC values against melanoma cells in melanoma patients was different from that in control subjects, and several sub-populations of melanoma patients were evident on the basis of these measurements. No difference in distribution of CMC values was found against non-melanoma cells, which suggested the changes were specific for melanoma. The proportion of patients with recurrence of melanoma was compared between the patient groups with low, normal or high CMC values against cultured melanoma cells after surgery. Analysis for periods extending to 2 years showed that patients with low CMC values after surgery had a significantly higher incidence of recurrence from melanoma than patients with normal or high CMC values. These results suggest there may be a sub-group of melanoma patients who have intrinsically low CMC against melanoma cells, and that this may be an important predisposing factor in the development of recurrent melanoma.

Full text

PDF
506

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson D. E. Clinical characteristics of the genetic variety of cutaneous melanoma in man. Cancer. 1971 Sep;28(3):721–725. doi: 10.1002/1097-0142(197109)28:3<721::aid-cncr2820280330>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  2. Anthony H. M., Kirk J. A., Madsen K. E., Mason M. K., Templeman G. H. E and EAC rosetting lymphocytes in patients with carcinoma of bronchus. II. A sequential study of thirty patients: effect of BCG. Clin Exp Immunol. 1975 Apr;20(1):41–54. [PMC free article] [PubMed] [Google Scholar]
  3. Baldwin R. W. In vitro assays of cell-mediated immunity to human solid tumors: problems of quantitation, specificity, and interpretation. J Natl Cancer Inst. 1975 Oct;55(4):745–748. doi: 10.1093/jnci/55.4.745. [DOI] [PubMed] [Google Scholar]
  4. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  5. Eilber F. R., Morton D. L. Impaired immunologic reactivity and recurrence following cancer surgery. Cancer. 1970 Feb;25(2):362–367. doi: 10.1002/1097-0142(197002)25:2<362::aid-cncr2820250213>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  6. Hellström I., Warner G. A., Hellström K. E., Sjögren H. O. Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma. Int J Cancer. 1973 Mar 15;11(2):280–292. doi: 10.1002/ijc.2910110206. [DOI] [PubMed] [Google Scholar]
  7. Herberman R. B., Oldham R. K. Problems associated with study of cell-mediated immunity to human tumors by microcytotoxicity assays. J Natl Cancer Inst. 1975 Oct;55(4):749–753. doi: 10.1093/jnci/55.4.749. [DOI] [PubMed] [Google Scholar]
  8. Hersey P., Edwards A., Edwards J., Adams E., Milton G. W., Nelson D. S. Specificity of cell-mediated cytotoxicity against human melanoma lines: evidence for "non-specific" killing by activated T-cells. Int J Cancer. 1975 Jul 15;16(1):173–183. doi: 10.1002/ijc.2910160119. [DOI] [PubMed] [Google Scholar]
  9. Hersey P., Edwards J., Edwards A., Adams E., Kearney R., Milton G. W. Comparison of 51Cr release and microcytotoxicity assays against human melanoma cells. Int J Cancer. 1975 Jul 15;16(1):164–172. doi: 10.1002/ijc.2910160118. [DOI] [PubMed] [Google Scholar]
  10. Hersey P., Honeyman M., Edwards A., Adams E., McCarthy W. H. Antigens on melanoma cells detected by leukocyte dependent antibody assays of human melanoma antisera. Int J Cancer. 1976 Nov 15;18(5):564–573. doi: 10.1002/ijc.2910180504. [DOI] [PubMed] [Google Scholar]
  11. Kiessling R., Bataillon G., Lamon E. W., Klein E. The lymphocyte response to primary Moloney sarcoma virus tumors: definition of a non-specific component of the in vitro cellular hyporeactivity of tumor-bearing hosts. Int J Cancer. 1974 Nov 15;14(5):642–648. doi: 10.1002/ijc.2910140511. [DOI] [PubMed] [Google Scholar]
  12. Kiessling R., Klein E., Wigzell H. "Natural" killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur J Immunol. 1975 Feb;5(2):112–117. doi: 10.1002/eji.1830050208. [DOI] [PubMed] [Google Scholar]
  13. Kirchner H., Chused T. M., Herberman R. B., Holden H. T., Lavrin D. H. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus. J Exp Med. 1974 Jun 1;139(6):1473–1487. doi: 10.1084/jem.139.6.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kiuchi M., Takasugi M. The nonselective cytotoxic cell (N cell). J Natl Cancer Inst. 1976 Mar;56(3):575–582. doi: 10.1093/jnci/56.3.575. [DOI] [PubMed] [Google Scholar]
  15. Mukherji B., Vassos D., Flowers A., Binder S. C., Nathanson L. Selective and non-selective lymphocytotoxicity in human melanoma: observation on the effect of long-term culture and fetal bovine serum on target-cell sensitivity to lymphocytes. Int J Cancer. 1975 Dec 15;16(6):971–980. doi: 10.1002/ijc.2910160611. [DOI] [PubMed] [Google Scholar]
  16. O'Toole C., Perlmann P., Unsgaard B., Moberger G., Edsmyr F. Cellular immunity to human urinary bladder carcinoma. I. Correlation to clinical stage and radiotherapy. Int J Cancer. 1972 Jul 15;10(1):77–91. doi: 10.1002/ijc.2910100111. [DOI] [PubMed] [Google Scholar]
  17. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Southam C. M. The immunologic status of patients with nonlymphomatous cancer. Cancer Res. 1968 Jul;28(7):1433–1440. [PubMed] [Google Scholar]
  19. Takasugi M., Koide D., Ramseyer A. Specificities in natural cell-mediated cytotoxicity by the cross-competition assay. Int J Cancer. 1977 Mar 15;19(3):291–297. doi: 10.1002/ijc.2910190303. [DOI] [PubMed] [Google Scholar]
  20. Takasugi M., Mickey M. R., Terasaki P. I. Studies on specificity of cell-mediated immunity to human tumors. J Natl Cancer Inst. 1974 Dec;53(6):1527–1538. [PubMed] [Google Scholar]
  21. Takasugi M., Ramseyer A., Takasugi J. Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression. Cancer Res. 1977 Feb;37(2):413–418. [PubMed] [Google Scholar]
  22. Twomey P. L., Catalona W. J., Chretien P. B. Proceedings: Cellular immunity in cured cancer patients. Cancer. 1974 Feb;33(2):435–440. doi: 10.1002/1097-0142(197402)33:2<435::aid-cncr2820330219>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  23. Veronesi U., Cascinelli N., Fossati G., Canevari S., Balzarini G. Lymphocyte toxicity test in clinical melanoma. Eur J Cancer. 1973 Nov-Dec;9(11-12):843–846. doi: 10.1016/0014-2964(73)90025-x. [DOI] [PubMed] [Google Scholar]
  24. Weese J. L., Herberman R. B., Perlin E., Mills M., Heims W., Blom J., Green D., Reid J., Bellinger S., Law I. Immunological monitoring and immunotherapy in carcinoma of the lung. Int J Cancer. 1976 Dec 15;18(6):739–749. doi: 10.1002/ijc.2910180604. [DOI] [PubMed] [Google Scholar]
  25. West W. H., Cannon G. B., Kay H. D., Bonnard G. D., Herberman R. B. Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells. J Immunol. 1977 Jan;118(1):355–361. [PubMed] [Google Scholar]
  26. de Vries J. E., Cornain S., Rumke P. Cytotoxity of non-T versus T-lymphocytes from melanoma patients and healthy donors on short- and long-term cultured melanoma cells,. Int J Cancer. 1974 Oct 15;14(4):427–434. doi: 10.1002/ijc.2910140402. [DOI] [PubMed] [Google Scholar]
  27. de Vries J. E., Rümke P. Tumour-associated lymphocyte cytotoxicity superimposed on "spontaneous" cytotoxicity in melanoma patients. Int J Cancer. 1976 Feb 15;17(2):182–190. doi: 10.1002/ijc.2910170206. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES